Yue Xie
Chaigoubu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Activation of AMP-activated protein kinase by compound 991 protects osteoblasts from dexamethasone.
Journal: Biochemical and biophysical research communications
Published: November 13, 2017
microRNA-19a protects osteoblasts from dexamethasone via targeting TSC1.
Journal: Oncotarget
Published: September 11, 2017
PP2A catalytic subunit silence by microRNA-429 activates AMPK and protects osteoblastic cells from dexamethasone.
Journal: Biochemical and biophysical research communications
Published: March 25, 2017
Icariside II activates EGFR-Akt-Nrf2 signaling and protects osteoblasts from dexamethasone.
Journal: Oncotarget
Published: November 07, 2016
MHY1485 activates mTOR and protects osteoblasts from dexamethasone.
Journal: Biochemical and biophysical research communications
Published: October 10, 2016
Activating AMP-activated protein kinase by an α1 selective activator compound 13 attenuates dexamethasone-induced osteoblast cell death.
Journal: Biochemical and biophysical research communications
Published: January 18, 2016
K6PC-5, a novel sphingosine kinase 1 (SphK1) activator, alleviates dexamethasone-induced damages to osteoblasts through activating SphK1-Akt signaling.
Journal: Biochemical and biophysical research communications
Published: January 23, 2015
Combination of bone marrow concentrate and PGA scaffolds enhancing bone marrow stimulation in the repair of rabbit articular cartilage
Journal: Zhonghua yi xue za zhi
Published: January 15, 2014
Selection of suitable procedure in the treatment of degenerative lumbar scoliosis based upon imaging studies
Journal: Zhonghua yi xue za zhi
Published: May 11, 2013
Treatment of degenerative lumbar scoliosis via posterior decompression and fusion with internal fixation
Journal: Zhonghua yi xue za zhi
Published: February 16, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026